Laura Elizabeth Lansdowne
The pharmaceutical company Achieve Life Sciences is focused on addressing one of the biggest public health threats globally – tobacco use. By developing treatment options for people who are battling nicotine addiction, it hopes to reduce the number of preventable deaths caused by smoking.
Technology Networks had the pleasure of speaking with Cindy Jacobs, MD, PhD and chief medical officer at Achieve Life Sciences to learn more about cytisinicline, a plant-based alkaloid the company is currently developing as a smoking cessation treatment.
Laura Lansdowne (LL): Tobacco use is one of the biggest public health threats globally. Could you elaborate on the current global tobacco and nicotine addiction epidemic, what strategies can be used to address this?
Cindy Jacobs (CJ): Smoking is the number one cause of preventable death and is responsible for 8 million premature deaths each year worldwide. Reducing these deaths requires a two-pronged approach. The first is educational outreach and implementation of policies that discourage people from starting to smoke. The second is making it easier for current smokers to quit, which in itself comprises multiple approaches. One of those is encouraging and facilitating candid and productive discussions between smokers and their healthcare providers about why they should quit and what resou